SOCS2 regulation of growth hormone signaling requires a canonical interaction with phosphotyrosine

Suppressor of cytokine signaling (SOCS) 2 is the critical negative regulator of growth hormone (GH) and prolactin signaling. Mice lacking SOCS2 display gigantism with increased body weight and length, and an enhanced response to GH treatment. Here, we characterized mice carrying a germ-line R96C mutation within the SOCS2-SH2 domain, which disrupts the ability of SOCS2 to interact with tyrosine-phosphorylated targets. Socs2(R96C/R96C) mice displayed a similar increase in growth as previously observed in SOCS2 null (Socs2(−/−)) mice, with a proportional increase in body and organ weight, and bone length. Embryonic fibroblasts isolated from Socs2(R96C/R96C) and Socs2(−/−) mice also showed a comparable increase in phosphorylation of STAT5 following GH stimulation, indicating the critical role of phosphotyrosine binding in SOCS2 function.